Market Cap

Celyad SA Market Capitalization:

€15.7 Million

EUR as of Jan. 1, 2024

US$17.3 Million

business Celyad SA Company Profile

Celyad SA Main Stock Listing

Euronext: CYAD

Market Capitalization History of Celyad SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Celyad SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 €15.7 M -68.27%
Jan. 1, 2023 €49.5 M -39.03%
Jan. 1, 2022 €81.2 M -51.66%
Jan. 1, 2021 €167.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Celyad SA Categories

Belgium languages Healthcare languages Biotechnology
Belgium Healthcare Belgium Biotechnology

Stocks & Indices

Celyad SA has the following listings and related stock indices.


Stock: Euronext: CYAD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.